Literature DB >> 1842573

Regional infusion chemotherapy for colorectal hepatic metastases--where is it going?

M J Dworkin1, T G Allen-Mersh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1842573     DOI： 10.1016/0305-7372(91)90013-p

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

1.  Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.

Authors:  D Burke; P Carnochan; C Glover; T G Allen-Mersh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Colorectal liver metastases.

Authors:  D Burke; T G Allen-Mersh
Journal:  Postgrad Med J       Date:  1996-08       Impact factor: 2.401

3.  Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.

Authors:  C Fordy; D Burke; S Earlam; P Twort; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

4.  Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.

Authors:  D Burke; C Fordy; S A Earlam; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Measurement of response to treatment in colorectal liver metastases.

Authors:  M J Dworkin; D Burke; S Earlam; C Fordy; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

6.  Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.

Authors:  M J Dworkin; P Carnochan; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.